Page last updated: 2024-10-25

clonidine and Cardiovascular Diseases

clonidine has been researched along with Cardiovascular Diseases in 22 studies

Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research Excerpts

ExcerptRelevanceReference
"The incidence of perioperative myocardial ischemia was significantly reduced with clonidine (intraoperative and postoperative, 18 of 125, 14% vs."5.11Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. ( Boisvert, DM; Galindez, D; Haratonik, KA; Kardatzke, D; Layug, EL; Lazo, EA; Salahieh, A; Wallace, AW, 2004)
"As clonidine has been associated with cardiovascular adverse effects, it should be administered only in cases where blood pressure regulation is mandatory."2.61Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk? ( Ampatzi, C; Goulis, DG; Mareti, E; Paschou, SA; Voziki, E, 2019)
" While medications for ADHD are generally well-tolerated, there are common, although less severe, as well as rare but severe adverse events AEs during treatment with ADHD drugs."2.49Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. ( Banaschewski, T; Buitelaar, J; Coghill, D; Cortese, S; Danckaerts, M; Dittmann, RW; Graham, J; Holtmann, M; Sergeant, J; Taylor, E, 2013)
"As clonidine is a well-known effector of the autonomous system, stimulating vagal tone and decreasing sympathetic activity, we compared the autonomous reactions of children with constitutional growth delay (CGD), growth hormone deficiency (GHD) and former small for gestational age (SGA)."1.42Modified Clonidine Testing for Growth Hormone Stimulation Reveals α2-Adrenoreceptor Sub Sensitivity in Children with Idiopathic Growth Hormone Deficiency. ( Buchhorn, R; Meint, S; Rager, K; Willaschek, C, 2015)
"Treatment with tizanidine was effective in 60% of the patients; there were high correlations between spasticity before and after tizanidine administration and the severity of symptoms and also between the degree of improvement in spasticity and in that of the symptoms."1.28Development of a simple spasticity quantification method: effects of tizanidine on spasticity in patients with sequelae of cerebrovascular disease. ( Asanuma, M; Hirata, H; Ogawa, N; Ota, Z; Yamamoto, M; Yamawaki, Y, 1992)

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19908 (36.36)18.7374
1990's4 (18.18)18.2507
2000's2 (9.09)29.6817
2010's8 (36.36)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oyama, JI1
Node, K1
Mareti, E1
Ampatzi, C1
Paschou, SA1
Voziki, E1
Goulis, DG1
Stone, LS1
German, JP1
Kitto, KF1
Fairbanks, CA1
Wilcox, GL1
Slawski, BA1
Cohn, SL1
Pfeifer, KJ1
Dutta, S1
Jaffer, AK1
Smetana, GW1
Cegarra-Sanmartin, V1
Paniagua-Iglesias, P1
Popova, E1
de Nadal Clanchet, M1
Alonso-Coello, P1
Plou, P1
Mata Mena, E1
Fernández-Riveira, C1
García del Valle, S1
Tena Blanco, B1
Sabaté Tenas, S1
Font Gual, A1
Maestre Hittinger, ML1
González Rodríguez, R1
Willaschek, C1
Meint, S1
Rager, K1
Buchhorn, R1
Katare, PB1
Banerjee, SK1
Schlaich, MP1
Socratous, F1
Hennebry, S1
Eikelis, N1
Lambert, EA1
Straznicky, N1
Esler, MD1
Lambert, GW1
Cortese, S1
Holtmann, M1
Banaschewski, T1
Buitelaar, J1
Coghill, D1
Danckaerts, M1
Dittmann, RW1
Graham, J1
Taylor, E1
Sergeant, J1
Wallace, AW1
Galindez, D1
Salahieh, A1
Layug, EL1
Lazo, EA1
Haratonik, KA1
Boisvert, DM1
Kardatzke, D1
Strain, JJ1
Liebowitz, MR1
Klein, DF1
Hayduk, K1
Halawa, B1
Zarifis, J1
Lip, GY1
Ferner, RE1
Conner, CS1
Watanabe, AS1
Guthrie, GP1
Genest, J1
Kuchel, O1
Flacke, JW1
Ogawa, N1
Asanuma, M1
Hirata, H1
Ota, Z1
Yamawaki, Y1
Yamamoto, M1
Pavlov, AA1
Rykin, BA1
Vanholder, R1
Lamiere, N1
Ringoir, S1
Houston, MC1
Almeyda, J1
Levantine, A1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Impact of Renal SympAthetic DenerVation on Chronic HypErtension[NCT01628198]38 participants (Actual)Interventional2011-10-31Terminated (stopped due to recommendation by the study's DSMB due to insufficient data to determine efficacy.)
Renal Sympathetic Denervation for the Management of Chronic Hypertension[NCT01628172]96 participants (Actual)Interventional2011-01-31Completed
Therapeutic Use of Repetitive Transcranial Magnetic Stimulation (rTMS) in Pediatric Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Cohorts (ADHD): a Randomized, Sham-controlled Study.[NCT06069323]80 participants (Anticipated)Interventional2023-06-01Recruiting
Hemodynamic Effect of Intrathecal Clonidine in Hypertensive Subjects: A Pilot Study to Assess Its Effectiveness in Hypertensive Subjects With Poor Blood Pressure Control (Phase II)[NCT01297335]Phase 210 participants (Actual)Interventional2011-02-28Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change in Ambulatory Diastolic Blood Pressure

The change in diastolic blood pressure as measured by 24 hour ambulatory monitoring at 6 months as compared to from baseline. (NCT01628198)
Timeframe: baseline and 6 months

InterventionmmHg mean change (Mean)
Renal Denervation Group-5.5

Mean Change in Ambulatory Systolic Blood Pressure

The change in systolic blood pressure as measured by 24 hour ambulatory monitoring at 6 months as compared to from baseline. (NCT01628198)
Timeframe: baseline and 6 months

InterventionmmHg (Mean)
Renal Denervation Group-10.2

Anti-hypertensive Medications

The total number of anti-hypertensive medications at baseline, 6 months, and 12 months (NCT01628198)
Timeframe: Baseline, 6 months, 12 months

Interventionmedications (Mean)
Baseline6 months12 months
Renal Denervation Group5.374.794.64

Blood Urea Nitrogen

A blood urea nitrogen (BUN) test measures the amount of nitrogen in blood that comes from the waste product urea. Urea is made when protein is broken down in the body. Urea is made in the liver and passed out in the urine. (NCT01628198)
Timeframe: baseline, 6 months, 12 months

Interventionmg/dL (Mean)
Baseline6 months12 months
Renal Denervation Group20.8222.1523.11

Creatinine

Creatinine measures the level of the waste product in the body. The amount of creatinine in the blood depends partly on the amount of muscle tissue you have. Men generally have higher creatinine levels than women.Normal levels of creatinine in the blood are approximately 0.6 to 1.2 milligrams (mg) per deciliter (dL) in adult males and 0.5 to 1.1 milligrams per deciliter in adult females. High levels of creatinine indicates kidney impairment. (NCT01628198)
Timeframe: baseline, 6 months, 12 months

Interventionmg/dl (Mean)
Baseline6 months12 months
Renal Denervation Group1.61.682.03

Office Diastolic BP

Different time points office diastolic blood pressure measurements (NCT01628198)
Timeframe: baseline, 6 month, 12 months

Interventionmm Hg (Mean)
Baseline6 months12 months
Renal Denervation Group87.0686.9387.75

Office Systolic BP

Different time points office systolic blood pressure measurements (NCT01628198)
Timeframe: baseline, 6 month, 12 months

Interventionmm Hg (Mean)
Baseline6 months12 months
Renal Denervation Group156.86151.19158.45

Renal Aortic Ratio

Renal artery blood flow as measured by Renal Aortic Ratio (RAR) = Peak systolic Velocity renal artery / Peak Systolic Velocity Aorta. A >60% stenosis is reported when there is a >3.5:1 Renal to Aortic Ratio. (NCT01628198)
Timeframe: Baseline and 12 months

Interventionratio (Mean)
Baseline Right RARBaseline Left RAR12 months Right RAR12 months Left RAR
Renal Denervation Group1.381.521.411.52

Renal Artery Dimensions

Dimensions of renal artery, right and left (NCT01628198)
Timeframe: baseline and 12 months

Interventionmm (Mean)
Baseline R KidneyBaseline L Kidney12 months R Kidney12 months L Kidney
Renal Denervation Group11.4311.6811.2611.39

Resistive Index

Renal artery blood flow as measured by Resistive Index. RI = (peak systolic velocity - end diastolic velocity ) / peak systolic velocity. the normal value is ~ 0.60, with 0.70 being around the upper limits of normal (NCT01628198)
Timeframe: Baseline and 12 months

Interventionindex (Mean)
Baseline Right RIBaseline Left RI12 months Right RI12 months Left RI
Renal Denervation Group0.670.720.720.72

Change in Blood Pressure After Intrathecal Injection of Clonidine.

"Subjects baseline blood pressure (systolic blood pressure (SBP), and diastolic blood pressure (DBP)), and blood pressures after clonidine injection was compared against baseline to assess efficacy of clonidine in refractory hypertensive subjects. Subject's blood pressure was monitored continuously after intrathecal injection of clonidine until subjects blood pressure nadir and return to pre clonidine injection level. The mean value reported below are the average changes in blood pressure from baseline (pre clonidine injection) in both SBP and DBP during post clonidine injection blood pressure monitoring for 4 hours.~Blood pressure measurements were collected every 10 minutes for first hour after injection, and every 15 minutes after the first hour, up to 4 hours were averaged to report the change from baseline." (NCT01297335)
Timeframe: Baseline, Every 10 Minutes for first hour after clonidine injection, and every 15 minutes after first hour, until 4 hours after clonidine injection

Interventionmm Hg (Mean)
Change in mean SBP after clonidine injectionChange in DBP after clonidine injection
Intrathecal Clonidine7937

Changes in Visual Analogue Scale (VAS) Ratings of Sedation and Sensation of Dry Mouth Reported by the Subjects, Pre and 1 Hour Post Injection

Subjects were asked to rate severity of two of the most common side effects of clonidine, sedation and sensation of dry mouth, at pre and post (1 hour after) intrathecal administration of clonidine. The mean changes between pre and post injection VAS ratings of sedation and sensation of dry mouth are reported below. The VAS scale ranges from 1 to 10 cm, with higher values indicating higher level of sedation and higher level of dry mouth. (NCT01297335)
Timeframe: Before clonidine injection (Baseline), and at 1 hour after clonidine injection.

Interventioncm (Mean)
Change in level of sedationChange in sensation of dry mouth
Intrathecal Clonidine3.363.47

Likert Scale Pain Rating

Likert scale is 11 point digital pain rating system that asks subjects to rate their pain from 0 to 10. Rating of 0 means no pain at all, and in increasing order, 10 would mean worst pain imaginable/ unbearable pain. (NCT01297335)
Timeframe: Pre-dose and 1 hour post injection.

Interventionunits on a scale (Mean)
Pre-injection average Likert scorePost-injection average Likert score
Intrathecal Clonidine6.53.6

Reviews

14 reviews available for clonidine and Cardiovascular Diseases

ArticleYear
Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk?
    Current vascular pharmacology, 2019, Volume: 17, Issue:6

    Topics: Cardiovascular Diseases; Clonidine; Female; Gabapentin; Humans; Menopause; Phytoestrogens; Pregabali

2019
Perioperative cardiovascular medicine: an update of the literature 2013-2014.
    Hospital practice (1995), 2014, Volume: 42, Issue:4

    Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiovascular Diseases; Clonidine; Heart Arrest; Humans; P

2014
Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario.
    Current topics in medicinal chemistry, 2016, Volume: 16, Issue:19

    Topics: Allopurinol; Aspirin; Bromocriptine; Cardiovascular Diseases; Clonidine; Colesevelam Hydrochloride;

2016
Sympathetic activation in chronic renal failure.
    Journal of the American Society of Nephrology : JASN, 2009, Volume: 20, Issue:5

    Topics: Animals; Cardiovascular Diseases; Catecholamines; Clonidine; Debrisoquin; Disease Models, Animal; Ef

2009
Sympathetic activation in chronic renal failure.
    Journal of the American Society of Nephrology : JASN, 2009, Volume: 20, Issue:5

    Topics: Animals; Cardiovascular Diseases; Catecholamines; Clonidine; Debrisoquin; Disease Models, Animal; Ef

2009
Sympathetic activation in chronic renal failure.
    Journal of the American Society of Nephrology : JASN, 2009, Volume: 20, Issue:5

    Topics: Animals; Cardiovascular Diseases; Catecholamines; Clonidine; Debrisoquin; Disease Models, Animal; Ef

2009
Sympathetic activation in chronic renal failure.
    Journal of the American Society of Nephrology : JASN, 2009, Volume: 20, Issue:5

    Topics: Animals; Cardiovascular Diseases; Catecholamines; Clonidine; Debrisoquin; Disease Models, Animal; Ef

2009
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.
    Journal of child psychology and psychiatry, and allied disciplines, 2013, Volume: 54, Issue:3

    Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure

2013
Anxiety and panic attacks in the medically ill.
    The Psychiatric clinics of North America, 1981, Volume: 4, Issue:2

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders;

1981
[Complications associated with sudden withdrawal of various drugs used in the treatment of cardiovascular diseases].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1981, Mar-15, Volume: 34, Issue:6

    Topics: Cardiovascular Diseases; Clonidine; Guanethidine; Humans; Nitroglycerin; Nitroprusside; Propranolol;

1981
Poisoning with anti-hypertensive drugs: methyldopa and clonidine.
    Journal of human hypertension, 1995, Volume: 9, Issue:10

    Topics: Antihypertensive Agents; Cardiovascular Diseases; Central Nervous System Diseases; Clonidine; Drug O

1995
Clonidine overdose: a review.
    American journal of hospital pharmacy, 1979, Volume: 36, Issue:7

    Topics: Adolescent; Adult; Cardiovascular Diseases; Child, Preschool; Clonidine; Coma; Female; Humans; Hypot

1979
Renin and the therapy of hypertension.
    Annual review of pharmacology and toxicology, 1976, Volume: 16

    Topics: Animals; Antihypertensive Agents; Cardiovascular Diseases; Clonidine; Diazoxide; Diuretics; Dogs; Fe

1976
Alpha 2-adrenergic agonists in cardiovascular anesthesia.
    Journal of cardiothoracic and vascular anesthesia, 1992, Volume: 6, Issue:3

    Topics: Adrenergic alpha-Agonists; Anesthesia; Animals; Cardiovascular Diseases; Clonidine; Dogs; Humans; St

1992
Therapeutic effect and complication profile of clonidine-beta-blocker combinations.
    Kidney international. Supplement, 1988, Volume: 25

    Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Drug Combinations; Humans; Hyperten

1988
Treatment of hypertensive emergencies and urgencies with oral clonidine loading and titration. A review.
    Archives of internal medicine, 1986, Volume: 146, Issue:3

    Topics: Blood Pressure; Cardiovascular Diseases; Clonidine; Drug Administration Schedule; Emergencies; Human

1986
Cutaneous reactions to cardiovascular drugs.
    The British journal of dermatology, 1973, Volume: 88, Issue:3

    Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Debrisoquin; Digitalis Glycosides;

1973

Trials

3 trials available for clonidine and Cardiovascular Diseases

ArticleYear
[Perioperative acetylsalicylic acid and clonidine in noncardiac surgery patients (POISE-2 trial)].
    Revista espanola de anestesiologia y reanimacion, 2015, Volume: 62, Issue:5

    Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Clo

2015
Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery.
    Anesthesiology, 2004, Volume: 101, Issue:2

    Topics: Adrenergic alpha-Agonists; Aged; Anesthesia; Arrhythmias, Cardiac; Cardiovascular Diseases; Catechol

2004
Therapeutic effect and complication profile of clonidine-beta-blocker combinations.
    Kidney international. Supplement, 1988, Volume: 25

    Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Drug Combinations; Humans; Hyperten

1988

Other Studies

6 other studies available for clonidine and Cardiovascular Diseases

ArticleYear
Is GRK2 a new target for cardiovascular disease?
    Hypertension research : official journal of the Japanese Society of Hypertension, 2018, Volume: 41, Issue:8

    Topics: Cardiovascular Diseases; Clonidine; Diabetes Mellitus; Humans; Hypertension

2018
Morphine and clonidine combination therapy improves therapeutic window in mice: synergy in antinociceptive but not in sedative or cardiovascular effects.
    PloS one, 2014, Volume: 9, Issue:10

    Topics: Analgesics; Animals; Cardiovascular Diseases; Clonidine; Dose-Response Relationship, Drug; Drug Syne

2014
Modified Clonidine Testing for Growth Hormone Stimulation Reveals α2-Adrenoreceptor Sub Sensitivity in Children with Idiopathic Growth Hormone Deficiency.
    PloS one, 2015, Volume: 10, Issue:9

    Topics: Adrenergic alpha-2 Receptor Agonists; Blood Pressure; Body Height; Cardiovascular Diseases; Child; C

2015
[Clonidine: new aspects of a known principle].
    MMW, Munchener medizinische Wochenschrift, 1983, May-20, Volume: 125, Issue:20

    Topics: Cardiovascular Diseases; Clonidine; Heart Failure; Humans; Hypertension

1983
Development of a simple spasticity quantification method: effects of tizanidine on spasticity in patients with sequelae of cerebrovascular disease.
    The Journal of international medical research, 1992, Volume: 20, Issue:1

    Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Clonidine; Female; Humans; Male; Middle Aged; Musc

1992
[Side effects of long-term drug therapy of patients with uncomplicated arterial hypertension in a polyclinic].
    Klinicheskaia meditsina, 1991, Volume: 69, Issue:8

    Topics: Adolescent; Adult; Antihypertensive Agents; Cardiovascular Diseases; Clonidine; Dose-Response Relati

1991